These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12808270)

  • 1. Effects of candesartan and probucol on restenosis after coronary stenting: results of insight of stent intimal hyperplasia inhibition by new angiotensin II receptor antagonist (ISHIN) trial.
    Wakeyama T; Ogawa H; Iida H; Takaki A; Iwami T; Mochizuki M; Tanaka T
    Circ J; 2003 Jun; 67(6):519-24. PubMed ID: 12808270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, randomized, placebo-controlled multicenter clinical trial to evaluate the effects of the angiotensin II receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation.
    Radke PW; Figulla HR; Drexler H; Klues HG; Mügge A; Silber S; Daniel W; Schmeisser A; Reifart N; Motz W; Büttner HJ; Fischer D; Ortlepp JR; Schaefers K; Hoffmann R; Hanrath P;
    Am Heart J; 2006 Oct; 152(4):761.e1-6. PubMed ID: 16996855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The angiotensin II receptor blocker candesartan cilexetil reduces neointima proliferation after coronary stent implantation: a prospective randomized study under intravascular ultrasound guidance.
    Yoshida O; Hirayama H; Nanasato M; Watanabe T; Murohara T
    Am Heart J; 2005 Jan; 149(1):e2. PubMed ID: 15660025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of probucol in inhibiting intimal hyperplasia after coronary stent implantation: a randomized study.
    Nunes GL; Abizaid AC; Theodoro MP; Brito FS; Caixeta A; da Silva LF; Mazzotti NG; Belló-Klein A; Clausell N
    Am Heart J; 2006 Nov; 152(5):914.e1-7. PubMed ID: 17070157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volumetric analysis of in-stent intimal hyperplasia in diabetic patients treated with or without abciximab: results of the Diabetes Abciximab steNT Evaluation (DANTE) randomized trial.
    Chaves AJ; Sousa AG; Mattos LA; Abizaid A; Staico R; Feres F; Centemero M; Tanajura LF; Abizaid A; Pinto I; Maldonado G; Seixas A; Costa MA; Paes A; Mintz GS; Sousa JE
    Circulation; 2004 Feb; 109(7):861-6. PubMed ID: 14757690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial.
    Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Kang SJ; Park SJ; Lee JH; Choi SW; Seong IW; Lee NH; Cho YH; Shin WY; Lee SJ; Lee SW; Hyon MS; Bang DW; Choi YJ; Kim HS; Lee BK; Lee K; Park HK; Park CB; Lee SG; Kim MK; Park KH; Park WJ;
    J Am Coll Cardiol; 2011 Mar; 57(11):1264-70. PubMed ID: 21392640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cilostazol on in-stent neointimal hyperplasia after coronary artery stenting: a quantative coronary angiography and volumetric intravascular ultrasound study.
    Min PK; Jung JH; Ko YG; Choi D; Jang Y; Shim WH
    Circ J; 2007 Nov; 71(11):1685-90. PubMed ID: 17965485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study.
    Schindler C; Mueller A; Bramlage P; Boecking W; Kirch W; Schweizer J
    Angiology; 2007 Dec-2008 Jan; 58(6):710-6. PubMed ID: 17928625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CAIRP (CAndesartan for In-stent Restenosis Prevention) Trial--a multicenter study of AT1-receptor blocker therapy in coronary stenting.
    Krämer J; Ruf RG; Schmidt S; Axthelm C; Strasser R; Janssen G; Thieme T; Kusch A; Waigand J; Dietz R; Gross CM
    J Invasive Cardiol; 2008 May; 20(5):205-10. PubMed ID: 18460701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A paclitaxel-eluting stent for the prevention of coronary restenosis.
    Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS
    N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of probucol and cilostazol alone and in combination on frequency of poststenting restenosis.
    Sekiya M; Funada J; Watanabe K; Miyagawa M; Akutsu H
    Am J Cardiol; 1998 Jul; 82(2):144-7. PubMed ID: 9678282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of probucol on neointimal thickening in a stent porcine restenosis model.
    Yokoyama T; Miyauchi K; Kurata T; Sato H; Daida H
    Jpn Heart J; 2004 Mar; 45(2):305-13. PubMed ID: 15090707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct stenting versus direct stenting followed by centered beta-radiation with intravascular ultrasound-guided dosimetry and long-term anti-platelet treatment: results of a randomized trial: Beta-Radiation Investigation with Direct Stenting and Galileo in Europe (BRIDGE).
    Serruys PW; Wijns W; Sianos G; de Scheerder I; van den Heuvel PA; Rutsch W; Glogar HD; Macaya C; Materne PH; Veldhof S; Vonhausen H; Otto-Terlouw PC; van der Giessen WJ
    J Am Coll Cardiol; 2004 Aug; 44(3):528-37. PubMed ID: 15358015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional stenting promotes intimal proliferation and compromises the results of intravascular radiation therapy: an intravascular ultrasound study.
    Cheneau E; Wu Z; Leborgne L; Ajani AE; Weissman N; Pichard AD; Satler LF; Kent KM; Mintz G; Waksman R
    Am Heart J; 2003 Jul; 146(1):142-5. PubMed ID: 12851623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients).
    Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Hong MK; Kim HS; Ko JK; Park JH; Lee JH; Choi SW; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Park SJ
    J Am Coll Cardiol; 2008 Mar; 51(12):1181-7. PubMed ID: 18355656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.
    Chen SL; Ye F; Zhang JJ; Zou JJ; Qian XS; Li F; Yang S; Ge Z; Shan SJ; Li XB; Xu T; Kan J; Lin L; Han YL
    Cardiovasc Ther; 2013 Aug; 31(4):193-200. PubMed ID: 22954234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the efficacy of dual antiplatelet therapy and the development of in-stent neointimal hyperplasia in porcine coronary arteries.
    Hemetsberger R; Farhan S; Strehblow C; Sperker W; Pavo I; Petrasi Z; Hemetsberger H; Posa A; Huber K; Glogar D; Gyöngyösi M
    Coron Artery Dis; 2008 Dec; 19(8):635-43. PubMed ID: 19005299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis.
    Dussaillant GR; Mintz GS; Pichard AD; Kent KM; Satler LF; Popma JJ; Wong SC; Leon MB
    J Am Coll Cardiol; 1995 Sep; 26(3):720-4. PubMed ID: 7642865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of anti-oxidant (carvedilol and probucol) loaded stents in a porcine coronary restenosis model.
    Kim W; Jeong MH; Cha KS; Hyun DW; Hur SH; Kim KB; Hong YJ; Park HW; Kim JH; Ahn YK; Kim MH; Cho JG; Park JT; Park JC; Kang JC
    Circ J; 2005 Jan; 69(1):101-6. PubMed ID: 15635212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
    Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.